Arsanis, Inc. (75) | Registration Rights Agreements (2)
- Registration Rights Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 19, 2021)
- Registration Rights Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 16, 2020)
